Bain Capital Life Sciences Investors, Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 14, 2026, Bain Capital Life Sciences Investors, Llc disclosed 20 stock positions valued at approximately $1.68B as of quarter-end June 30, 2026. The largest holdings include KAILERA THERAPEUTICS INC, HEARTFLOW INC, and NEWAMSTERDAM PHARMA COMPANY.

Report Period
June 30, 2026
No. of Stocks
20
Portfolio Value
$1.68B
Holdings by Sector
Bain Capital Life Sciences Investors, Llc Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
KAILERA THERAPEUTICS INCKLRAHealthcare29.58%22,583,268+22,583,268+100.00%$497,509,394
HEARTFLOW INCHTFLHealthcare14.74%8,448,158-2,000,000-19.14%$247,868,956
NEWAMSTERDAM PHARMA COMPANYNAMSWOther7.67%3,806,566-3,500,000-47.90%$129,004,522
SAVARA INCSVRAHealthcare6.45%17,600,621--$108,419,826
ALKERMES PLCALKSHealthcare6.04%1,937,938+1,327,938+217.69%$101,538,262
SOLID BIOSCIENCES INCSLDBHealthcare5.83%9,808,819--$97,990,102
PHARVARIS N VPHVSHealthcare5.50%2,675,509--$92,519,101
OLEMA PHARMACEUTICALS INCOLMAHealthcare5.27%7,085,249-387,989-5.19%$88,636,465
HEMAB THERAPEUTICS HOLDINGS INCCOAGHealthcare3.60%1,650,000+1,650,000+100.00%$60,604,500
CABALETTA BIO INCCABAHealthcare3.19%17,241,445+7,564,320+78.17%$53,620,894
X4 PHARMACEUTICALS INCXFORHealthcare2.21%7,967,454--$37,208,011
DIANTHUS THERAPEUTICS INCDNTHHealthcare2.10%362,470--$35,333,576
C4 THERAPEUTICS INCCCCCHealthcare1.99%7,171,910--$33,492,820
KYVERNA THERAPEUTICS INCKYTXHealthcare1.53%2,885,000-225,000-7.23%$25,705,350
ANNEXON INCANNXHealthcare1.51%4,437,731-774,943-14.87%$25,339,444
RAPID MICRO BIOSYSTEMS INCRPIDHealthcare0.87%8,434,560--$14,591,789
DISC MEDICINE INCIRONHealthcare0.61%141,234--$10,329,855
ATEA PHARMACEUTICALS INCAVIRHealthcare0.57%2,075,639-284,999-12.07%$9,651,721
XILIO THERAPEUTICS INCXLOHealthcare0.38%664,021--$6,361,322
UPSTREAM BIO INCUPBHealthcare0.25%600,949-266,262-30.70%$4,158,567
Showing 20 of 20 holdings in the latest reporting period.